Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $103.01 million. The enterprise value is -$28,505.

Market Cap	103.01M
Enterprise Value	-28,505

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025, before market open.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 50.74 million shares outstanding. The number of shares has increased by 11.17% in one year.

Current Share Class	50.74M
Shares Outstanding	50.74M
Shares Change (YoY)	+11.17%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	2.98%
Owned by Institutions (%)	66.78%
Float	43.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.85
P/TBV Ratio	0.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.24.

Current Ratio	3.96
Quick Ratio	3.88
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-128.83

Financial Efficiency

Return on equity (ROE) is -73.85% and return on invested capital (ROIC) is -44.13%.

Return on Equity (ROE)	-73.85%
Return on Assets (ROA)	-41.37%
Return on Invested Capital (ROIC)	-44.13%
Return on Capital Employed (ROCE)	-102.36%
Revenue Per Employee	n/a
Profits Per Employee	-$772,927
Employee Count	164
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.00% in the last 52 weeks. The beta is 2.72, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.72
52-Week Price Change	-84.00%
50-Day Moving Average	1.41
200-Day Moving Average	3.04
Relative Strength Index (RSI)	75.02
Average Volume (20 Days)	2,002,197

Short Selling Information

The latest short interest is 6.10 million, so 12.02% of the outstanding shares have been sold short.

Short Interest	6.10M
Short Previous Month	5.80M
Short % of Shares Out	12.02%
Short % of Float	14.04%
Short Ratio (days to cover)	6.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-134.25M
Pretax Income	-89.98M
Net Income	-126.76M
EBITDA	-132.44M
EBIT	-134.25M
Earnings Per Share (EPS)	-$2.57

Full Income Statement

Balance Sheet

The company has $131.83 million in cash and $28.79 million in debt, giving a net cash position of $103.04 million or $2.03 per share.

Cash & Cash Equivalents	131.83M
Total Debt	28.79M
Net Cash	103.04M
Net Cash Per Share	$2.03
Equity (Book Value)	121.55M
Book Value Per Share	2.40
Working Capital	100.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.04 million and capital expenditures -$2.18 million, giving a free cash flow of -$97.22 million.

Operating Cash Flow	-95.04M
Capital Expenditures	-2.18M
Free Cash Flow	-97.22M
FCF Per Share	-$1.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.17%
Shareholder Yield	-11.17%
Earnings Yield	-123.06%
FCF Yield	-94.38%

Analyst Forecast

The average price target for Cabaletta Bio is $20.33, which is 901.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.33
Price Target Difference	901.48%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.98%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1